Experience With Topical Acne Treatment

NCT05582434 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Acne

Interventions

DRUG: clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel
DRUG: adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel
DRUG: Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]